619: N-[(E)-3-[(2R,3S,4R,5R)-5-(6-ethylaminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]prop-2-enyl]-5-(4-fluorophenyl)-2,3-dihydroxy-benzamide
619 is a Ligand Of Interest in 5LQA designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 5LQA_619_A_302 | 100% | 42% | 0.028 | 0.991 | 1.09 | 1.07 | 3 | 3 | 0 | 0 | 100% | 1 |
| 3HVI_619_A_267 | 99% | 41% | 0.035 | 0.986 | 0.84 | 1.33 | 1 | 8 | 0 | 0 | 100% | 1 |
| 5LQU_619_B_301 | 99% | 34% | 0.042 | 0.98 | 1.02 | 1.47 | 3 | 7 | 4 | 0 | 100% | 1 |
